Pharmacology of cyclic analogues of deamino-oxytocin not containing a disulphide bond (carba analogues).

No abstract is available for this paper.

• Publication year

  1973

• Venue

  European Journal of Pharmacology

• Publication date

  1973-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0014-2999(73)90070-8PMID 4797285
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inactivation of deamino-carba analogues of oxytocin in the rat uterus, liver and kidney

  1972cited by this paper
• Amino acids and peptides. CV. Synthesis of deamino-[1,6-homolanthionine]-oxytocin, an analog of deamino-oxytocin with enlarged ring, lacking the disulfide bond

  1972cited by this paper
• Natriferic and hydroosmotic potencies of deamino-oxytocin analogues with no disulphide bridge

  1972cited by this paper
• Amino acids and peptides. C. The effect of the presence of sulphur atoms on the biological activity of oxytocin; Synthesis of deamino-carba 6 -oxytocin and deamino-dicarba-oxytocin

  1971cited by this paper
• Amino acids and peptides. XCIX. An improved synthesis of deamino-carba 1 -oxytocin comparison of various methods for peptide cyclisation

  1971cited by this paper
• Amino acids and peptides. CIV. Synthesis of two analogues of deamino-oxytocin with a diminished ring not containing a disulphide bond

  1971cited by this paper
• Crystalline deamino-dicarba-oxytocin. Preparation and some pharmacological properties.

  1970cited by this paper
• Oxytocin Analogues Containing No Disulfide Bond. I. Synthesis of the Lactam of L-Tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-α-aminosuberyl-L-prolyl-L-leucylglycine Amide

  1969cited by this paper
• Determination of rate constants of drug elimination from the receptor compartment by an infusion method: neurohypophysial hormones and their structural analogues.

  1969cited by this paper
• Synthesis of a biologically active analog of deamino-8-arginine-vasopressin which does not contain a disulphide bond

  1969cited by this paper
• Effect of magnesium on the action of oxytocin and a group of analogues on the uterus in vitro.

  1968cited by this paper
• Synthesis of an Analogue of Desamino-lysine-vasopressin Containing No Disulfide Bond

  1968cited by this paper
• Determination of antidiuretic activity in the rat for structural analogues of the neurohypophysial hormones.

  1967cited by this paper
• The action of oxytocin and synthetic analogues on the isolated mammary-gland myoepithelium of the lactating rat; effect of some ions.

  1967cited by this paper
• Deamino-oxytocin. Its isolation by partition chromatography on Sephadex and crystallization from water, and its biological activities.

  1965cited by this paper
• THE POTENTIATING ACTION OF MAGNESIUM AND MANGANESE ON THE OXYTOCIC EFFECT OF SOME OXYTOCIN ANALOGUES.

  1965cited by this paper
• The effect of increasing the size of the ring present in deamino-oxytocin by one methylene group on its biological properties. The synthesis of 1-gamma-mercaptobutyric acid-oxytocin.

  1965cited by this paper
• A biologically active analogue of oxytocin not containing a disulfide group

  1964cited by this paper
• Assay of oxytocin by rat mammary gland in vitro.

  1962cited by this paper
• Synthesis of desamino-desoxyoxytocin, a biologically active analogue of oxytocin.

  1962cited by this paper
• Influence of the structure of theN-terminal extremity ofα-MSH on the melanophore stimulating activity of this hormone

  1961cited by this paper
• The Synthesis of 1-(Hemi-homocystine)-oxytocin and A Study of Some of its Pharmacological Properties1

  1961cited by this paper
• Effect of magnesium ion on the response of the rat uterus to neurohypophysial hormones and analogues.

  1960cited by this paper
• A modification of the method of Dale and Laidlaw for standardization of posterior pituitary extract.

  1948cited by this paper
• A new method for the assay of posterior pituitary extracts

  1938cited by this paper

• Oxytocin Analogues for the Oral Treatment of Abdominal Pain.

  2024cites this paper
• Carbetocin versus oxytocin following vaginal and Cesarean delivery: a before-after study

  2021cites this paper
• α-Conotoxin Peptidomimetics: Probing the Minimal Binding Motif for Effective Analgesia

  2020cites this paper
• Cyclic Peptide Design

  2019cites this paper
• Design of Oxytocin Analogs.

  2019cites this paper
• What does basic science tell us about the use of uterotonics?

  2019cites this paper
• Uterotonics in elective caesarean delivery: a randomised non‐inferiority study comparing carbetocin 20 μg and 100 μg

  2018cites this paper
• Kinetics of oxytocin and deaminooxytocin displacement from the OXTR‐receptor compartment in rat uterus ex vivo

  2018cites this paper
• Potent and selective oxytocin receptor agonists without disulfide bridges.

  2017cites this paper
• Carbetocin at Cesarean delivery for labour arrest: a sequential allocation trial to determine the effective dose

  2015cites this paper
• PRODUCTIVE AND REPRODUCTIVE PERFORMANCES OF PRIMIPAROUS FRIESIAN COWS IN RELATION WITH UTERINE INVOLUTION INDUCED BY OXYTOCIN AND PROSTAGLANDIN OF ADMINISTRATION AT CALVING

  2015cites this paper
• UTERINE INVOLUTION AND REPRODUCTIVE PERFORMANCE OF LACTATING FRIESIAN COWS TREATED WITH OXYTOCIN AND PROSTAGLANDIN (PGF2α) AT CALVING

  2013cites this paper
• Carbetocin at elective Cesarean delivery: a randomized controlled trial to determine the effective dose, part 2

  2012cites this paper
• 44 Carbetocin for the Prevention of Postpartum Hemorrhage

  2012cites this paper
• Carbetocin at elective Cesarean delivery: a randomized controlled trial to determine the effective dose

  2012cites this paper
• The effect of a single oxytocin or carbetocin treatment on uterine contractility in early postpartum dairy cows.

  2006cites this paper
• Physiological and clinical aspects of uterine contractility during the postpartum period in cows

  2005cites this paper
• The polyuric syndromes.

  2001cites this paper
• Endocrine Control of Water Balance

  1999influential citation
• Conformational and structural considerations in oxytocin-receptor binding and biological activity.

  1990cites this paper
• Uterotonic activity and myometrial receptor affinity of 1-deamino-1-carba-2-tyrosine(O-methyl)-oxytocin.

  1987cites this paper
• Chapter 4 – Structure–Activity Relationships of Neurohypophyseal Peptides

  1987cites this paper
• Effect of threonine in position 4 in oxytocin and vasotocin analogs on the time course of uterotonic response.

  1987cites this paper
• CHAPTER 7 – Structure–Activity of the Neurohypophyseal Hormones and Analogs and Implications for Hormone–Receptor Interactions

  1986cites this paper
• A synthetic deamino-carba-analogue of oxytocin with a raised natriuretic-diuretic effect in rats.

  1983cites this paper
• Neurohypophysial peptides. Design of tissue-specific agonists and antagonists.

  1981cites this paper
• Effect of some oxytocin analogues on natriuresis in rats.

  1980cites this paper
• Effect of deamino-dicarba-oxytocin and oxytocin on myoelectrical and mechanical activity of uterus, stomach and small intestine in dog.

  1979cites this paper
• Actions of oxytocin and a long-acting carba oxytocin analog on the porcine myometrium in vitro and in vivo.

  1979cites this paper
• Regulation of bovine labor with a long-acting carba-analog of oxytocin: a preliminary report.

  1979cites this paper
• Structural requirements for activation of vasopressin-sensitive adenylate cyclase, hormone binding, and antidiuretic actions: effects of highly potent analogues and competitive inhibitors.

  1978cites this paper
• Vasopressin-dependent adenylate cyclase activities in the rat kidney medulla: evidence for two separate sites of action.

  1978cites this paper
• Synthesis and some pharmacological properties of [4-threonine, 7-glycine]oxytocin, [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine, 7-glycine]oxytocin (hydroxy[Thr4, Gly7]oxytocin), and [7-Glycine]oxytocin, peptides with high oxytocic-antidiuretic selectivity.

  1977cites this paper
• Synthesis and some pharmacological properties of [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine]oxytocin (hydroxy [4-thr]oxytocin), a peptide with strikingly high oxytocic potency and of [1-(L-2-hydroxy-3-mercaptopropanoic acid)]oxytocin (hydroxy-oxytocin).

  1976cites this paper
• MODES OF INACTIVATION OF NEUROHYPOPHYSIAL HORMONES: SIGNIFICANCE OF PLASMA DISAPPEARANCE RATE FOR THEIR PHYSIOLOGICAL RESPONSES

  1976cites this paper
• Regional and Systemic Haemodynamic Effects of Some Vasopressins: Structural Features of the Hormone which Prolong Activity

  1975cites this paper
• Role of the disulfide bridge and the C-terminal tripeptide in the antidiuretic action of vasopressin in man and the rat.

  1975cites this paper
• NEUROPHYSIN BINDING AND NATRIURETIC PEPTIDES FROM THE POSTERIOR PITUITARY

  1975cites this paper
• Milk-ejecting and uterotonic activities of oxytocin analogues in rats.

  1975cites this paper
• Regional and Systemic Haemodynamic Effects of Some Vasopressins: Structural Features of the Hormone which Prolong Activity

  1975cites this paper